BD announces first-quarter fiscal 2010 results

BD (Becton, Dickinson and Company) (NYSE: BDX) today reported quarterly revenues of $1.917 billion for the first fiscal quarter ended December 31, 2009, representing an increase of 12 percent from the prior-year period, or 9 percent on a foreign currency-neutral basis.  

"We are pleased with our solid start to fiscal 2010.  Our BD Medical and BD Diagnostics segments led our revenue growth, aided by flu-related sales," said Edward J. Ludwig, Chairman and Chief Executive Officer.  "Our revenue growth, good operating performance and a stabilizing Biosciences business this quarter give us the confidence to raise guidance for fiscal 2010."

Diluted earnings per share from continuing operations for the quarter were $1.30, an increase of 4 percent over diluted earnings per share from continuing operations of $1.25 for the first quarter of 2009.  On a foreign currency-neutral basis, diluted earnings per share from continuing operations for the first quarter of fiscal 2010 increased 11 percent.

Segment Results

In the BD Medical segment, worldwide revenues for the quarter were $1.019 billion, representing an increase of 16 percent from the prior-year period, or 13 percent on a foreign currency-neutral basis.  Strong sales of Medical Surgical Systems and Pharmaceutical Systems products, including about 7 percentage points from flu-related products, as well as Diabetes Care products contributed to revenue growth.

In the BD Diagnostics segment, worldwide revenues for the quarter were $595 million, representing an increase of 10 percent from the prior-year period, or 8 percent on a foreign currency-neutral basis.   Sales of safety-engineered devices and infectious disease testing systems, including about 2 percentage points from flu-related products, contributed to revenue growth.

In the BD Biosciences segment, worldwide revenues of $303 million for the quarter were flat compared with the prior-year period.  Revenues increased less than 1 percent on a foreign currency-neutral basis.  Demand for clinical and research instruments, as expected, continues to be impacted by capital funding constraints.

Geographic Results

First quarter revenues in the U.S. were $873 million, representing an increase of 10 percent from the prior-year period.  Revenues outside the U.S. were $1.044 billion, representing an increase of 13 percent from the prior-year period, or 8.5 percent on a foreign currency-neutral basis.

Fiscal 2010 Outlook

We expect reported revenues for the full fiscal year 2010 to increase approximately 7 percent, or 6 percent on a foreign currency-neutral basis, compared with our prior guidance of 6 percent, or 5 percent on a foreign currency-neutral basis.

We also expect diluted earnings per share from continuing operations for the full fiscal year 2010 to increase approximately 2 to 4 percent, to $5.05 to $5.15, over adjusted diluted earnings per share from continuing operations, excluding specified items, of $4.95 for the fiscal year 2009, or 8 to 10 percent on a foreign currency-neutral basis.  Our prior guidance was an increase of 1 to 3 percent, or 7 to 9 percent on a foreign currency-neutral basis.

SOURCE BD (Becton, Dickinson and Company)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Becton, Dickinson and Company. (2010, January 28). BD announces first-quarter fiscal 2010 results. News-Medical. Retrieved on May 26, 2020 from https://www.news-medical.net/news/20100128/BD-announces-first-quarter-fiscal-2010-results.aspx.

  • MLA

    Becton, Dickinson and Company. "BD announces first-quarter fiscal 2010 results". News-Medical. 26 May 2020. <https://www.news-medical.net/news/20100128/BD-announces-first-quarter-fiscal-2010-results.aspx>.

  • Chicago

    Becton, Dickinson and Company. "BD announces first-quarter fiscal 2010 results". News-Medical. https://www.news-medical.net/news/20100128/BD-announces-first-quarter-fiscal-2010-results.aspx. (accessed May 26, 2020).

  • Harvard

    Becton, Dickinson and Company. 2010. BD announces first-quarter fiscal 2010 results. News-Medical, viewed 26 May 2020, https://www.news-medical.net/news/20100128/BD-announces-first-quarter-fiscal-2010-results.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
BD introduces new informatics and automation solutions for clinical laboratories